RAYMUNDO TRINANES: Open Payments
NPI 1487727095 · PEARL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 38 payments from 13 companies in 2025. Trend: 2023 $294 · 2024 $209 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $154 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $125 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| JAZZ PHARMACEUTICALS INC. | 2 | $66 |
| ABBVIE INC. | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Lundbeck LLC | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
Products named: REXULTI, LUMRYZ, Sunosi, Auvelity, XYWAV, VRAYLAR, TRINTELLIX, CAPLYTA.
Industry payments across MS — which companies pay providers there.
